In support of TJ1988, see the ANS last week of trading after 3...

First 65 Last

Share
Profile

Follow
grubarura

11,485 Posts.

584

18/04/18

08:05

Post #: 32514652
Share

Originally posted by rolf2903 ↑

I don’t think I’ve ever seen someone more positive in the face of overwhelming adversity than you tj. It borders on dillusion. You’ve seen the quality of management (any problem that could conceivably be encountered they have achieved). You’ve seen the complete lack of interest in literally anyone investing further in these assets, this includes the project partner (who opted out of paying), your illustrious leader (who won’t put virtually any of his own money in to progress this) and shareholders (who pretty much all passed up the rights issue). Nobody believes the current management with the current assets makes a worthwhile investment. The only people who appeared to be interested were the drillers who took a royalty interest instead of being paid... but that was because they hadn’t been paid and almost certainly would have been told that if they push the issue they will fold the company. No other reason they would do it.
The company is not only in a precarious situation, it’s almost in an untenable one. Your fearless leader won’t pull a rabbit out of the hat in my view... he will self protect and give away almost the entire project for a pittance free ride (and negotiate sort out some sort of hidden “bonus” for himself on his own shares with the buyer). This guy is not going to look after you. His latest words say it all... he doesn’t genuinely accept responsibility for any of this. Awful awful awful leadership.

Expand

In support of TJ1988, see the ANS last week of trading after 3 Years of suspension and the holders comments

PRL Price at posting: 0.3¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Failure to report prompts ASX to impose multiple company suspensions

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

IRE

Iress runs 'hot' for Wealth Within's stock tips

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals